Background: Acute Myeloid Leukaemia (AML) is considered to be an extremely heterogeneous malignancy of bone marrow and blood. The first line of therapy for AML is prolonged chemotherapy. Due to the presence of molecular heterogeneity in AML as confirmed by next-generation sequencing, researchers are planning to develop newer strategies of therapy. Objective: In the present study we have explored the anti-cancer potentiality of the hydro-ethanolic extract (50% and 70%) of the whole flower of Nymphaea caerulea against the Acute Myeloid Leukaemia cell line, THP-1 with control of normal human kidney epithelial cell line (HEK 293). The present study is a novel contribution to the existing scientific knowledge as at present no study as an anti-leukaemic agent is available on N. caerulea (blue lotus) extract and exploring its action mechanism on in-vitro cell line model. Methods: Some targeted cytokine and apoptotic genes genes to deduce the anti-cancer mechanism of action of the crude extract (hydro-ethanolic extract (50% and 70%) of the whole flower) were selected as Interferon (IFN) γ, Interleukins – IL-6, IL-8, IL- 10, IL-1β, Transforming Growth Factor (TGF β1), Tumor Necrosis Factor (TNF α), Caspase 3(CAS 3), Caspase 9 (CAS 9), CD95 (Fas), Tumor Necrosis Factor Receptor 1 (TNFRSF1A) to observe relative fold changes of the expression using Real-Time PCR with housekeeping gene β-actin. Cellular cytopathic effect (CPE), cell viability assay by methylene blue assay, and cell cytotoxicity of the crude extract against the THP-1 cell line were also studied along with it’s bio-active compositional analysis of the extract was explored using ultra-performance liquid chromatography followed by mass spectra. Results: The N. caerulea flower extract is capable of inducing apoptosis in AML and it can balance cytokine alterations in such diseases. Conclusions: Nymphaea caerulea flower extract appears to be a good anti-leukemia agent.
Chatterjee, D., Singh, B., Paira, K., & Das, S. (2024). The Apoptotic Property of Nymphaea Caerulea Flower Extract on Acute Myeloid Leukaemia Cell Line, THP-1. Asian Pacific Journal of Cancer Prevention, 25(1), 123-137. doi: 10.31557/APJCP.2024.25.1.123
MLA
Debasmita Chatterjee; Banhishikha Singh; Krishnendu Paira; Satadal Das. "The Apoptotic Property of Nymphaea Caerulea Flower Extract on Acute Myeloid Leukaemia Cell Line, THP-1". Asian Pacific Journal of Cancer Prevention, 25, 1, 2024, 123-137. doi: 10.31557/APJCP.2024.25.1.123
HARVARD
Chatterjee, D., Singh, B., Paira, K., Das, S. (2024). 'The Apoptotic Property of Nymphaea Caerulea Flower Extract on Acute Myeloid Leukaemia Cell Line, THP-1', Asian Pacific Journal of Cancer Prevention, 25(1), pp. 123-137. doi: 10.31557/APJCP.2024.25.1.123
VANCOUVER
Chatterjee, D., Singh, B., Paira, K., Das, S. The Apoptotic Property of Nymphaea Caerulea Flower Extract on Acute Myeloid Leukaemia Cell Line, THP-1. Asian Pacific Journal of Cancer Prevention, 2024; 25(1): 123-137. doi: 10.31557/APJCP.2024.25.1.123
)